Rotenone Use in Fish Management and Parkinson's Disease: Another Look

被引:7
|
作者
Finlayson, Brian [1 ]
Schnick, Rosalie [2 ,3 ]
Skaar, Don [4 ]
Anderson, Jon [5 ]
Demong, Leo [6 ]
Duffield, Dan [7 ]
Horton, William [8 ]
Steinkjer, Jarle [9 ]
VanMaaren, Chris [10 ]
机构
[1] Calif Dept Fish & Game, Camino, CA 95709 USA
[2] Michigan State Univ, La Crosse, WI 54603 USA
[3] US Fish & Wildlife Serv, La Crosse, WI 54603 USA
[4] Montana Fish Wildlife & Pk, Helena, MT 59620 USA
[5] Washington Dept Fish & Wildlife, Olympia, WA 98501 USA
[6] New York Dept Environm Conservat, Vermontville, NY 12989 USA
[7] US Forest Serv, USDA, Ogden, UT 84401 USA
[8] Idaho Dept Fish & Game, Boise, ID 83707 USA
[9] Norwegian Directorate Nat Management, N-7485 Trondheim, Norway
[10] New York Dept Environm Conservat, Watertown, NY 13601 USA
关键词
SYSTEM; RATS;
D O I
10.1080/03632415.2012.723963
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
引用
收藏
页码:471 / 474
页数:4
相关论文
共 50 条
  • [41] Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease
    Tiago Zaminelli
    Raísa Wendhausen Gradowski
    Taysa Bervian Bassani
    Janaína Kohl Barbiero
    Ronise M. Santiago
    Daniele Maria-Ferreira
    Cristiane Hatsuko Baggio
    Maria A. B. F. Vital
    Neurotoxicity Research, 2014, 26 : 351 - 362
  • [42] The Rotenone Models Reproducing Central and Peripheral Features of Parkinson's Disease
    Miyazaki, Ikuko
    Asanuma, Masato
    NEUROSCI, 2020, 1 (01):
  • [43] Rotenone model of Parkinson's disease: The dosing options in mice revisited
    Raza, M.
    Zehra, N.
    Malhi, S.
    MOVEMENT DISORDERS, 2018, 33 : S405 - S405
  • [44] Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
    Drolet, Robert E.
    Cannon, Jason R.
    Montero, Laura
    Greenamyre, J. Timothy
    NEUROBIOLOGY OF DISEASE, 2009, 36 (01) : 96 - 102
  • [45] PARAQUAT- AND ROTENONE-INDUCED MODELS OF PARKINSON'S DISEASE
    Nistico, R.
    Mehdawy, B.
    Piccirilli, S.
    Mercuri, N.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (02) : 313 - 322
  • [46] Effects of agomelatine in rotenone-induced Parkinson's disease in rats
    Gunaydin, Caner
    Avci, Bahattin
    Bozkurt, Ayhan
    Onger, Mehmet Emin
    Balci, Hakan
    Bilge, S. Sirri
    NEUROSCIENCE LETTERS, 2019, 699 : 71 - 76
  • [47] A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease
    Huang, J
    Liu, HQ
    Gu, WW
    Yan, Z
    Xu, ZH
    Yang, YX
    Zhu, XZ
    Li, YP
    BIOMATERIALS, 2006, 27 (06) : 937 - 946
  • [48] Implication of autophagy in Parkinson's disease: rotenone-based models
    Xiong, N.
    Jia, M.
    Xiong, J.
    Huang, J.
    Wang, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 657 - 657
  • [49] Dysregulation of striatal neurotransmitter release in the rotenone model of Parkinson's disease
    Sperlágh, B
    Milusheva, E
    Baranyi, M
    Kittel, A
    Vizi, ES
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 120 - 120
  • [50] Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
    Ulusoy, Gokhan K.
    Celik, Turgay
    Kayir, Hakan
    Gursoy, Murat
    Isik, Ahmet T.
    Uzbay, Tayfun I.
    BRAIN RESEARCH BULLETIN, 2011, 85 (06) : 380 - 384